A randomized phase 2 study comparing different dose-approaches of induction treatment (first cycle) of regorafenib in metastatic colorectal cancer (mCRC) patients

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 09 Nov 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

14 Oct 2022 Results assessing the safety and efficacy of two regorafenib dose-escalation approaches in refractory metastatic colorectal cancer patients, published in the European Journal of Cancer.
09 Mar 2020 Status changed from active, no longer recruiting to completed.
10 Apr 2019 Planned End Date changed from 1 Jan 2019 to 1 Sep 2019.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com